Related Experiment Video
Updated: Jun 4, 2026
08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Mitotic catastrophe in malignant epithelial tumors: the pathologist's viewpoint
Rosario Caruso1, Francesco Fedele, Roberta Lucianò
1Department of Human Pathology, University of Messina, Messina, Italy. rosariocaruso@tin.it
Ultrastructural Pathology
|February 9, 2011
Summary
Mitotic catastrophe, a cell death pathway in cancer, occurs when tumor cells with faulty p53 function undergo abnormal cell division. Understanding this process aids in cancer research and therapeutic design.
Area of Science:
- Cell Biology
- Cancer Research
- Pathology
Background:
- Mitotic catastrophe is a cell death mechanism observed in tumor cells with compromised p53 tumor suppressor function.
- Exposure to cytotoxic and genotoxic agents can trigger this phenomenon in cancer cells.
Observation:
- Defective p53 checkpoints lead to errors in chromosome segregation during mitosis.
- This results in aberrant mitosis, multinucleation, and centrosome abnormalities.
Findings:
- While a precise definition is lacking, mitotic catastrophe links cell cycle checkpoints to cell death.
- Morphological signs are present in aggressive neoplasms like giant cell carcinomas.
Implications:
- Mitotic catastrophe offers a unifying morphological concept for cancer research.
- Its inclusion in tumor evaluation can enhance understanding of tumor progression and guide novel therapeutic strategies.
- Potential exists for integrating mitotic catastrophe into prognostic scoring systems.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...